I love the combination of low debt with low payout ratios. The debt situation is one of the most important issues in corporate finance. It also expresses the ability to grow sales and earnings by enlarging the balance sheet with bank loans.
Only a low leveraged corporation has potential to boost sales without taking new investors into the boat that dilute the current earnings per share.
Today I would like to start an article series about low leveraged stocks from several sectors with currently small dividend payouts. I believe it's good to see what companies have the biggest potential to give shareholders huge amounts of money back in the near future and believe me, the tech sector is not the only place to be.
My criteria are a low dividend payout ratio of less than 20 percent as well as a debt-to-equity ratio under 0.5. Only twelve stocks fulfilled these very tight defined criteria.
One result is a high-yield, and nine stocks are recommended to buy or better. Most of the results come from the medical appliances and supplies or equipment industry.
These are the three cheapest results by forward P/E:
Humana (HUM) has a market capitalization of $14.92 billion. The company employs 43,400 people, generates revenue of $39.126 billion and has a net income of $1.222 billion. Humana's earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $2.354 billion. The EBITDA margin is 6.02 percent (the operating margin is 5.15 percent and the net profit margin 3.12 percent).
Financial Analysis: The total debt represents 14.69 percent of Humana's assets and the total debt in relation to the equity amounts to 33.18 percent. Due to the financial situation, a return on equity of 14.45 percent was realized by Humana. Twelve trailing months earnings per share reached a value of $9.40. Last fiscal year, Humana paid $1.03 in the form of dividends to shareholders. The dividend payout ratio of HUM amounts to 11.1 percent.
Market Valuation: Here a! re the price ratios of the company: The P/E ratio is 10.14, the P/S ratio is 0.38 and the P/B ratio is finally 1.70. The dividend yield amounts to 1.14 percent and the beta ratio has a value of 1.02.
Chemed (CHE) has a market capitalization of $1.34 billion. The company employs 14,096 people, generates revenue of $1.430 billion and has a net income of $89.30 million. Chemed's earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $199.24 million. The EBITDA margin is 13.93 percent (the operating margin is 10.94 percent and the net profit margin 6.24 percent).
Financial Analysis: The total debt represents 20.34 percent of Chemed's assets and the total debt in relation to the equity amounts to 38.58 percent. Due to the financial situation, a return on equity of 20.60 percent was realized by Chemed. Twelve trailing months earnings per share reached a value of $4.41. Last fiscal year, Chemed paid $0.68 in the form of dividends to shareholders. The dividend payout ratio of CHE amounts to 16 percent.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 16.34, the P/S ratio is 0.91 and the P/B ratio is finally 2.85. The dividend yield amounts to 1.15 percent and the beta ratio has a value of 0.40.
Zimmer Holdings (ZMH) has a market capitalization of $13.97 billion. The company employs 9,300 people, generates revenue of $4.471 billion and has a net income of $752.90 million. Zimmer Holdings earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $1.661 billion. The EBITDA margin is 37.16 percent (the operating margin is 23.42 percent and the net profit margin 16.84 percent).
Financial Analysis: The total debt represents 20.20 percent of Zimmer Holdings assets and the total debt in relation to the equity amounts to 31.07 percent. Due to the financial situation, a return on equity of 13.28 percent was realized by Zimmer Holdings. Twelve trailing months earnings per share reached a value of $4.06. La! st fiscal! year, Zimmer Holdings paid $0.54 in the form of dividends to shareholders. The dividend payout ratio of ZMH amounts to 18.60 percent.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 20.32, the P/S ratio is 3.10 and the P/B ratio is finally 2.39. The dividend yield amounts to 0.98 percent and the beta ratio has a value of 1.18.
Take a closer look at the full list of low debt healthcare dividend stocks with big potential to boost dividends. The average P/E ratio amounts to 20.22 and forward P/E ratio is 17.66. The dividend yield has a value of 1.16 percent. Price to book ratio is 2.90 and price to sales ratio 3.76. The operating margin amounts to 23.72 percent and the beta ratio is 0.75. Stocks from the list have an average debt to equity ratio of 0.22.
Do you like this article? If yes, please support us and hit the button for a Facebook Like, make a tweet or post a comment in the Dividend Yield community! Thank you so much, we really appreciate it.
Related Stock Ticker Symbols:
DXR, RMD, HUM, CHE, ATRI, ZMH, MLAB, TMO, IVC, AGN, CMN, COO
Selected Articles:
· 17 High Momentum Healthcare Dividend Stocks
· The Best Healthcare Dividend Stocks And Which Of Them Are The Cheapest
· 13 Highly Shorted Healthcare Dividend Stocks
· 20 Best Yielding Healthcare Stocks Less Volatile Than The Market
*If you would like to receive more dividend stock ideas and the free Dividend Weekly, you should subscribe to my free e-mail list. Alternatively, you can follow me on Facebook or Twitter.
No comments:
Post a Comment